Cargando…
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
Galectin-3 is a member of the galectin family, which are β-galactoside-binding lectins with ≥1 evolutionary conserved carbohydrate-recognition domain. It binds proteins in a carbohydrate-dependent and -independent manner. Galectin-3 is predominantly located in the cytoplasm; however, it shuttles int...
Autores principales: | Dong, Rui, Zhang, Min, Hu, Qunying, Zheng, Shan, Soh, Andrew, Zheng, Yijie, Yuan, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752178/ https://www.ncbi.nlm.nih.gov/pubmed/29207027 http://dx.doi.org/10.3892/ijmm.2017.3311 |
Ejemplares similares
-
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
por: Shi, Yuanwei, et al.
Publicado: (2022) -
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
por: Liu, Dan, et al.
Publicado: (2023) -
Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010) -
Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021) -
Galectin-3: a novel biomarker for the prognosis of heart failure
por: AMIN, HILMAN ZULKIFLI, et al.
Publicado: (2017)